Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease

Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly protective vaccines against coronaviruses that cause severe disease, for anticipating novel pandemic-causing viruses, and to respond more effectively to SARS-CoV-2 variants. The emergence of the Omicron variant of SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Panpan, Song, Ge, He, Wan-ting, Beutler, Nathan, Tse, Longping V., Martinez, David R., Schäfer, Alexandra, Anzanello, Fabio, Yong, Peter, Peng, Linghang, Dueker, Katharina, Musharrafieh, Rami, Callaghan, Sean, Capozzola, Tazio, Yuan, Meng, Liu, Hejun, Limbo, Oliver, Parren, Mara, Garcia, Elijah, Rawlings, Stephen A., Smith, Davey M., Nemazee, David, Jardine, Joseph G., Wilson, Ian A., Safonova, Yana, Rogers, Thomas F., Baric, Ralph S., Gralinski, Lisa E., Burton, Dennis R., Andrabi, Raiees
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923106/
https://www.ncbi.nlm.nih.gov/pubmed/35291291
http://dx.doi.org/10.1101/2022.03.04.479488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923106/
https://www.ncbi.nlm.nih.gov/pubmed/35291291
http://dx.doi.org/10.1101/2022.03.04.479488

Ejemplares similares